Skip to main content
TipRanks
Go Ultimate75% OFF

Arvinas Holding Company (ARVN) Drug Pipeline

1,055 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Pembrolizumab, Soc, Arv-6723Advanced Solid Tumorphase1AndPhase2RecruitingA Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid TumorsJul 17, 2026―
Arv-806Advanced Solid Cancer, Kras G12d Mutationphase1AndPhase2Active Not RecruitingA Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D MutationJun 09, 2025
Arv-393Relapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (Nhl), Relapsed/Refractory (R/R) Angioimmunoblastic T-Cell Lymphoma (Aitl)Phase IRecruitingA Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.Apr 25, 2024
Vepdegestrant, Pf-07220060Breast Cancerphase1AndPhase2Active Not RecruitingA Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.Dec 13, 2023―
Anastrozole, Arv-471, Surgical Resection Of Breast TumorBreast CancerPhase IICompletedA Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to SurgerySep 07, 2022―
Arv-110Prostate Cancer Metastaticphase1AndPhase2CompletedTrial of ARV-110 in Patients With Metastatic Castration Resistant Prostate CancerMar 21, 2019―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Arvinas Holding Company (ARVN) have in its pipeline
Arvinas Holding Company ARVN is currently developing the following drugs: Pembrolizumab, Soc, Arv-6723, Arv-806, Arv-393, Vepdegestrant, Pf-07220060, Anastrozole, Arv-471, Surgical Resection Of Breast Tumor, Arv-110. These drug candidates are in various stages of clinical development as the company works toward FDA approval.